Quick Answer
CNBX Pharmaceuticals Inc. reported Gross Profit of $5.7 thousand for fiscal year 2017.
CNBX Pharmaceuticals Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2017 | $5.7K | -94.9% |
| 2016 | $112.5K | — |
| 2015 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| February 28, 2025 | $0.00 | -100.0% | -100.0% |
| February 29, 2024 | $34.4K | — | — |
| February 28, 2023 | $0.00 | — | -100.0% |
| November 30, 2018 | $3.3K | +88.0% | +71.2% |
| February 28, 2018 | $1.9K | +55.3% | +9.8% |
| November 30, 2017 | $1.8K | — | +11.9% |
| May 31, 2017 | $1.6K | -96.9% | +26.4% |
| February 28, 2017 | $1.2K | -90.1% | — |
- CNBX Pharmaceuticals Inc. showed a decrease of -94.9% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from CNBX Pharmaceuticals Inc.’s fiscal year 2017 report (Form 10-K), filed with the SEC on December 8, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: